Amit Gupta - Procter Gamble CFO Director
| PGHL Stock | 5,299 159.20 3.10% |
Director
Amit Gupta is CFO Director of Procter Gamble Health
| Age | 48 |
| Address | P&G Plaza, Mumbai, India, 400099 |
| Phone | 91 22 6866 9000 |
| Web | https://www.pghealthindia.com |
Amit Gupta Latest Insider Activity
Tracking and analyzing the buying and selling activities of Amit Gupta against Procter Gamble stock is an integral part of due diligence when investing in Procter Gamble. Amit Gupta insider activity provides valuable insight into whether Procter Gamble is net buyers or sellers over its current business cycle. Note, Procter Gamble insiders must abide by specific rules, including filing SEC forms every time they buy or sell Procter Gamble'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Amit Gupta over a month ago Disposition of 22607 shares by Amit Gupta of Cardlytics at 3.845 subject to Rule 16b-3 | ||
Amit Gupta over a month ago Disposition of 7543 shares by Amit Gupta of Cardlytics at 3.085 subject to Rule 16b-3 | ||
Amit Gupta over a month ago Disposition of 14350 shares by Amit Gupta of Cardlytics subject to Rule 16b-3 | ||
Amit Gupta over three months ago Disposition of 43750 shares by Amit Gupta of Cardlytics subject to Rule 16b-3 |
Procter Gamble Management Efficiency
The company has return on total asset (ROA) of 0.1847 % which means that it generated a profit of $0.1847 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3118 %, meaning that it generated $0.3118 on every $100 dollars invested by stockholders. Procter Gamble's management efficiency ratios could be used to measure how well Procter Gamble manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Procter Gamble's Total Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 866.7 M in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 683.8 M in 2024.Similar Executives
| Found 8 records | DIRECTOR Age | ||
| Nitin Kantak | Mangalore Chemicals Fertilizers | 65 | |
| Kamidi Reddy | KNR Constructions Limited | 53 | |
| Pragya Barwale | India Glycols Limited | 42 | |
| Yerramilli Pashanth | Alkali Metals Limited | N/A | |
| Y Prashanth | Alkali Metals Limited | N/A | |
| Doraiswami Balaji | Kingfa Science Technology | 62 | |
| Pabitra Bhattacharya | Krebs Biochemicals and | 55 | |
| Govind Parmar | Indo Borax Chemicals | 65 | |
Management Performance
| Return On Equity | 0.31 | ||||
| Return On Asset | 0.18 |
Procter Gamble Health Leadership Team
Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Milind MBA, MD Director | ||
| Zeal Shah, Compliance Sec | ||
| Abhijit Roy, Director Sales | ||
| Rekha Bijoykumar, Manager Communications | ||
| Lars Atorf, Head Communications | ||
| Amit Gupta, CFO Director | ||
| Renee Connolly, Head Communications | ||
| Lokesh Chandak, Finance CFO | ||
| Sunil Punjabi, India Science | ||
| Zeal Rupani, Company Officer | ||
| Prachi Vichare, Assistant Secretary |
Procter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.31 | ||||
| Return On Asset | 0.18 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 85.75 B | ||||
| Shares Outstanding | 16.6 M | ||||
| Shares Owned By Insiders | 52.17 % | ||||
| Shares Owned By Institutions | 16.53 % | ||||
| Price To Book | 16.34 X | ||||
| Price To Sales | 7.45 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Procter Stock Analysis
When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.